Using advanced imaging techniques to detect lung disease early
Official title: Quantitative Optical Imaging Biomarkers of Interstitial Lung Disease
Funded at Massachusetts General Hospital · NIH-11051879 · Data updated 2026-11-12
This study is looking at a new way to spot and track interstitial lung disease (ILD) earlier and more accurately using a special imaging technique combined with artificial intelligence, so patients can get better diagnoses and see how well their treatments are working.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | April 1, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $186,680 |
| NIH project number | 5K25HL169846-02 |
| Project ID | NIH-11051879 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with interstitial lung disease who require ongoing monitoring of their condition.
✕Less likely to help
Patients with other types of lung diseases or those who do not have interstitial lung disease may not benefit from this research.
What this research studies
This research focuses on improving the early detection and monitoring of interstitial lung disease (ILD) using a technique called Optical Coherence Tomography (OCT). By combining OCT with artificial intelligence, the study aims to accurately identify and measure changes in lung tissue over time, allowing for better diagnosis and treatment evaluation. Patients will undergo minimally invasive imaging procedures, and the data collected will be analyzed to quantify disease progression in a more efficient manner. The goal is to enhance the ability to diagnose ILD early and assess how well treatments are working.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and more effective monitoring of interstitial lung disease, improving patient outcomes.
How similar studies have gone: Previous research has shown that similar imaging techniques can effectively diagnose lung diseases, suggesting a promising avenue for this approach.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Nandy, Sreyankar — Massachusetts General Hospital
- Study coordinator: Nandy, Sreyankar
Related research
Other NIH-funded projects on the same topics.
-
Obinutuzumab for CTD-Related Interstitial Lung Disease in adults
This project tests whether the anti-B cell therapy obinutuzumab can help adults with connective tissue disease–related ILD who are on mycophenolate therapy.
-
Obinutuzumab for connective tissue disease–related interstitial lung disease in adults
A study will test whether Obinutuzumab, given with standard treatments, can help adults with CTD-ILD breathe better and have fewer disease-related problems.
-
Risk factors and biomarkers for progression of subclinical RA-related lung disease
This study follows people with rheumatoid arthritis to understand who develops lung disease and what biomarkers predict it.
-
Understanding how a cell protein (SLC9A1) drives skin and lung scarring in systemic sclerosis
A five-year NIH grant aims to understand how a specific cell protein called SLC9A1 influences scar-forming cells in systemic sclerosis and related lung disease, with the goal of finding possible therapies.
-
From proteins and genes to new treatments for scar-related lung disease
A large NIH grant is working to map the proteins in the lungs of people with systemic sclerosis to find new targets for drugs that could slow or stop lung fibrosis.
-
Vasculopathy in Systemic Sclerosis and Lung Disease in Adults
A study in adults with systemic sclerosis will look at how blood vessels in the lungs and body relate to the development of lung disease, with the aim of finding new ways to prevent it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.